Vertex Pharmaceuticals Incorporated (VRTX)

There are only 12 investing days left in 2025. Now is a great time to load up on stocks that may win next year -- and over time....

Castleark Management LLC trimmed its stake in Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) by 98.4% during the undefined quarter, according to the company in its most recent disclosure with the ...

Ameriprise Financial Inc. lowered its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) by 2.4% in the undefined quarter, according to its most recent disclosure with the SEC. T...

Vertex (VRTX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects....

Apple's fiercely loyal customer base gives it a built-in market for any new devices it might launch in the future. MercadoLibre is positioned to grow rapidly in the Latin America e-commerce and fintec...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores....

Nu Holdings, Phillips 66, Vertex Pharmaceuticals and Disney get shoutouts on CNBC's "Halftime Report Final Trades."...

Federated Hermes Inc. boosted its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) by 13.9% in the second quarter, according to the company in its most recent 13F filing with the SEC. Th...

Cerity Partners LLC boosted its position in Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) by 4.3% in the undefined quarter, according to its most recent filing with the SEC. The fund owned 263,69...

Vertex Pharmaceuticals is the worldwide leader in cystic fibrosis treatment -- and its drugs have generated blockbuster revenue. The company has expanded into other therapeutic areas in recent years a...